Today at the San Antonio Breast Cancer Symposium, real world economics shared the stage with basic science when attendees learned that high insurance co-pays are limiting therapy for patients, in a study entitled: Association between Prescription Co-Payment Amount and Compliance with Adjuvant Aromatase Inhibitor Therapy in Women with Early Stage Breast Cancer.

For more information from SABCS 2010, please click here: SABCS 2010.

Produced by The Doctor’s Channel